(866) 280-3417 Call for Free Case Review
Select Page

Omontys Drug Lawsuit LawyersOmontys Lawsuits: Hypersensitivity, Allergic Reactions, Stroke, & Other Injuries

Commonly asked questions about Omontys (peginesatide):

What is Omontys?

Omontys is an injectable drug used to treat anemia in dialysis patients with chronic kidney disease. It was manufactured by Affymax, Inc. and Takeda Pharmaceutical Company.

Following reports of serious hypersensitivity and allergic reactions, including anaphylaxis, caused by Omontys, Affymax and Takeda issued a voluntary recall of the drug.

What are Complications of Omontys?

The most serious complication of Omontys is anaphylaxis, a severe, potentially life-threatening allergic reaction. It causes your immune system to release a flood of chemicals that can escalate into anaphylactic shock, which occurs when your blood pressure drops suddenly and your airways narrow, blocking breathing.

Dialysis centers in the United States submitted 19 reports of anaphylaxis caused by Omontys. This high rate of severe allergic reactions led to the drug being recalled. The drug manufacturers instructed that Omontys should not be provided to any new patients, and the FDA warned that all current treatment with Omontys should be immediately stopped.

Other complications include hypersensitivity and less severe allergic reactions. Omontys is also associated with muscle pain, upper respiratory infections, and adverse cardiovascular reactions, such as hypertension or stoke. These side effects, however, are less prevalent than allergic reactions.

Complications from Omontys can be so severe that fatal reactions have been reported in patients following just the first dose of intravenous administration. Serious hypersensitivity, allergic reactions, and anaphylactic shock have occurred within just 30 minutes of the drug’s administration.

Was Omontys Recalled?

On February 23, 2013, Affymax and Takeda voluntarily recalled all lots of Omontys. The companies also issued a letter to healthcare professionals instructing that no new or existing patients should receive Omontys as treatment.

Since its launch, Omontys was administered to over 25,000 patients. Reports indicated that prior to the recall, fatal reactions occurred in approximately 0.02% of patients following the first dose of intravenous administration. The rate of incidence for hypersensitivity reactions reached approximately 0.2%, a third of which were serious in nature, including anaphylaxis requiring prompt medical intervention.

All lots of Omontys were included in the recall, including:

  • 10 mg Multi-Doe vials – Lots C18685, C18881, C19258
  • 20 mg Multi-Dose vials – Lots C18686, C18696

What are the Criteria for Filing an Omontys Lawsuit?

If you or a loved one were harmed by taking Omontys, you could be entitled to compensation for your injuries. If you wish to file a lawsuit against the drug manufacturers, certain criteria must be met.

Potential clients must have taken the recalled medication. If you have chronic kidney disease, you must be on dialysis as well.

We are no longer reviewing cases of anaphylactic shock caused by Omontys, but we will look into cases where patients experienced other injuries as a result of the medication. Injuries could include stroke, hypertension, and others. We are reviewing these on a case by case basis.

In most cases, lawsuits are filed when severe injuries resulted in hospitalization.

Can I File an Omontys Lawsuit?

Our dangerous drug attorneys can help if you or someone you care about was injured as a result of taking Omontys.

Lawsuits have been filed against Affymax and Takeda by both patients and their families seeking compensation for injuries caused by this dangerous drug. You may be entitled to a settlement.

Settlements in Omontys lawsuits include compensation for your pain and suffering, as well as the medical bills incurred from treatment.

We do not charge any legal fees unless you receive a settlement and we pay all of the case costs. If your claim is not successful for any reason, you do not owe us anything. We put it all in writing for you.

Our No-Fee Promise on Omontys Cases

You can afford to have our great team of lawyers on your side. When you choose us, it literally costs nothing to get started. We promise you in writing:

  • No money to get started
  • We pay all case costs and expenses
  • No legal fees whatsoever unless you receive a settlement
  • Phone calls are always free.

How Do I Start An Omontys Claim?

Our lawyers will help you file your lawsuit. To get started, you can:

  1. Submit the Free Case Review Box on this page, or
  2. Call (866) 280-3417 any time of day to tell us about your case.

We will listen to your story and answer your questions. If you have claim, we will start immediately.

WARNING: There are strict time deadlines for filing Omontys injury lawsuit claims.

Omontys Lawsuit Lawyer Review

Drug Lawsuit Source Client Review
Review Date
Reviewed
Prescription Drug Lawyer
Client Rating
5